Education

06/2018 - Radiation Oncology Residency, Cedars-Sinai Medical Center
06/2014 - Internal Medicine Internship, Kaiser
MD, 06/2013 - , UC Davis

Selected Publications

  1. Mvemba A, Liang J, Swanson M, Yoshida E, Ueda S, Fuh K, Chen LM, Cham S. Fragmented Care and Guideline-Concordant Treatment in Locally Advanced Cervical Cancer. Obstet Gynecol. 2025 Apr 01; 145(4):387-394.  View on PubMed
  2. Ueno Y, Yoshida E, Nojiri S, Kato T, Ohtsu T, Takeshita T, Suzuki S, Yoshida H, Kato K, Itoh M, Notomi T, Usui K, Sozu T, Terao Y, Kawaji H, Kato H. Use of clinical variables for preoperative prediction of lymph node metastasis in endometrial cancer. Jpn J Clin Oncol. 2024 Jan 07; 54(1):38-46.  View on PubMed
  3. Parker JE, Yoshida EJ, Gien LT, Slomovitz BM, Nagel C. Vulvar cancer management and wrangling recurrent disease: A report from the society of gynecologic oncology journal club. Gynecol Oncol Rep. 2023 Dec; 50:101310.  View on PubMed
  4. Ni L, Sinha S, Rara M, Phuong C, Chen LM, Hsu IJ, Yoshida EJ. The role of adjuvant radiation therapy in older patients with node-positive vulvar cancer: A national cancer database analysis. Gynecol Oncol. 2022 11; 167(2):189-195.  View on PubMed
  5. Hsu IC, Yoshida E. Ultrasound guidance for cervical implantation. Int J Gynecol Cancer. 2022 03; 32(3):266-272.  View on PubMed
  6. Abel MK, Shui AM, Melisko M, Chien AJ, Yoshida EJ, Lancaster EM, Van 't Veer L, Esserman LJ, Mukhtar RA. The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study. NPJ Breast Cancer. 2021 Dec 21; 7(1):156.  View on PubMed
  7. Korenaga TK, Yoshida EJ, Pierson W, Chang J, Ziogas A, Swanson ML, Chapman JS, Sinha S, Chen LM. Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer. Gynecol Oncol. 2022 02; 164(2):348-356.  View on PubMed
  8. Sinha S, Lazar A, Lam A, Anderson EM, Chen LM, Hsu IJ, Yoshida EJ. Adjuvant radiation followed by chemotherapy is associated with improved overall survival in endometrial cancer. Gynecol Oncol. 2020 10; 159(1):30-35.  View on PubMed
  9. Yoshida EJ, Luu M, Freeman M, Essner R, Gharavi NM, Shiao SL, Mallen-St Clair J, Hamid O, Ho AS, Zumsteg ZS. The association between facility volume and overall survival in patients with Merkel cell carcinoma. J Surg Oncol. 2020 Aug; 122(2):254-262.  View on PubMed
  10. Inoue S, Hirota Y, Ueno T, Fukui Y, Yoshida E, Hayashi T, Kojima S, Takeyama R, Hashimoto T, Kiyono T, Ikemura M, Taguchi A, Tanaka T, Tanaka Y, Sakata S, Takeuchi K, Muraoka A, Osuka S, Saito T, Oda K, Osuga Y, Terao Y, Kawazu M, Mano H. Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations. Nat Commun. 2019 12 19; 10(1):5785.  View on PubMed
  11. Yoshida EJ. Save the Surgery for Salvage. Int J Radiat Oncol Biol Phys. 2019 11 15; 105(4):693-694.  View on PubMed
  12. Sittig MP, Luu M, Yoshida EJ, Scher K, Mita A, Shiao SL, Lu DJ, Mallen-St Clair J, Ho AS, Zumsteg ZS. Impact of insurance on survival in patients < 65 with head & neck cancer treated with radiotherapy. Clin Otolaryngol. 2020 01; 45(1):63-72.  View on PubMed
  13. Yoshida EJ, Luu M, Mallen-St Clair J, Mita AC, Scher KS, Lu DJ, Nguyen AT, Shiao SL, Ho AS, Zumsteg ZS. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments? Cancer. 2020 01 01; 126(1):58-66.  View on PubMed
  14. Toll SA, Jones MT, Yoshida EJ, Dhall G, Olch AJ, Wong KK. The relationship between ventricular volume and whole-brain irradiation dose in central nervous system germ cell tumors. Pediatr Blood Cancer. 2019 12; 66(12):e28005.  View on PubMed
  15. Aro K, Ho AS, Luu M, Kim S, Tighiouart M, Yoshida EJ, Mallen-St Clair J, Shiao SL, Leivo I, Zumsteg ZS. Survival Impact of Adjuvant Therapy in Salivary Gland Cancers following Resection and Neck Dissection. Otolaryngol Head Neck Surg. 2019 06; 160(6):1048-1057.  View on PubMed
  16. Lam A, Yoshida EJ, Bui K, Katrivesis J, Fernando D, Nelson K, Abi-Jaoudeh N. Demographic and facility volume related outcomes in radiofrequency ablation for early-stage hepatocellular carcinoma. HPB (Oxford). 2019 07; 21(7):849-856.  View on PubMed
  17. Lam A, Yoshida EJ, Bui K, Katrivesis J, Fernando D, Nelson K, Abi-Jaoudeh N. Patient and Facility Demographics Related Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated with Radiofrequency Ablation: A National Cancer Database Analysis. J Vasc Interv Radiol. 2018 11; 29(11):1535-1541.e2.  View on PubMed
  18. Lam A, Yoshida EJ, Bui K, Fernando D, Nelson K, Abi-Jaoudeh N. A National Cancer Database Analysis of Radiofrequency Ablation versus Stereotactic Body Radiotherapy in Early-Stage Non-Small Cell Lung Cancer. J Vasc Interv Radiol. 2018 09; 29(9):1211-1217.e1.  View on PubMed
  19. Aro K, Ho AS, Luu M, Kim S, Tighiouart M, Clair JM, Yoshida EJ, Shiao SL, Leivo I, Zumsteg ZS. Development of a novel salivary gland cancer lymph node staging system. Cancer. 2018 08 01; 124(15):3171-3180.  View on PubMed
  20. Yoshida EJ, Luu M, David JM, Kim S, Mita A, Scher K, Shiao SL, Tighiouart M, Ho AS, Zumsteg ZS. Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification. Head Neck. 2018 06; 40(6):1228-1236.  View on PubMed

Go to UCSF Profiles, powered by CTSI